StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a research report on Monday, August […]
StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Wednesday. The firm issued a buy rating on the biopharmaceutical company’s stock. A number of other equities research analysts have also recently commented on the company. HC Wainwright decreased their price target on Alimera Sciences from $9.00 […]
Shares of Alimera Sciences, Inc. (NASDAQ:ALIM – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.40 and traded as high as $3.71. Alimera Sciences shares last traded at $3.59, with a volume of 12,211 shares trading hands. Wall Street Analysts Forecast […]
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note published on Monday. The firm issued a buy rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the company. Alliance Global Partners upgraded Alimera Sciences from a neutral rating to a buy rating […]
StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report issued on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. ALIM has been the subject of several other research reports. Alliance Global Partners raised shares of Alimera Sciences from a neutral rating to a buy rating […]